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Abstract
Background: Lipoteichoic acid (LTA) is a component of Gram-positive bacterial cell walls, which has been found
to be elevated in cerebrospinal fluid of patients suffering from meningitis. Moreover, matrix metalloproteinases
(MMPs), MMP-9 especially, have been observed in patients with brain inflammatory diseases and may contribute to
brain disease pathology. However, the molecular mechanisms underlying LTA-induced MMP-9 expression in brain
astrocytes remain unclear.
Objective: The goal of this study was to examine whether LTA-induced cell migration is mediated by calcium/
calmodulin (CaM)/CaM kinase II (CaMKII)-dependent transactivation of the PDGFR pathway in rat brain astrocytes
(RBA-1 cells).
Methods: Expression and activity of MMP-9 induced by LTA was evaluated by zymographic, western blotting, and
RT-PCR analyses. MMP-9 regulatory signaling pathways were investigated by treatment with pharmacological
inhibitors or using dominant negative mutants or short hairpin RNA (shRNA) transfection, and chromatin
immunoprecipitation (ChIP)-PCR and promoter activity reporter assays. Finally, we determined the cell functional
changes by cell migration assay.
Results: The data show that c-Jun/AP-1 mediates LTA-induced MMP-9 expression in RBA-1 cells. Next, we
demonstrated that LTA induces MMP-9 expression via a calcium/CaM/CaMKII-dependent transactivation of PDGFR
pathway. Transactivation of PDGFR led to activation of PI3K/Akt and JNK1/2 and then activated c-Jun/AP-1
signaling. Activated-c-Jun bound to the AP-1-binding site of the MMP-9 promoter, and thereby turned on
transcription of MMP-9. Eventually, up-regulation of MMP-9 by LTA enhanced cell migration of astrocytes.
Conclusions: These results demonstrate that in RBA-1 cells, activation of c-Jun/AP-1 by a CaMKII-dependent PI3K/
Akt-JNK activation mediated through transactivation of PDGFR is essential for up-regulation of MMP-9 and cell
migration induced by LTA. Understanding the regulatory mechanisms underlying LTA-induced MMP-9 expression
and functional changes in astrocytes may provide a new therapeutic strategy for Gram-positive bacterial infections
in brain disorders.
Background
Bacterial infections are responsible for a number of
inflammatory diseases including brain inflammation [1].
Gram-positive bacterial infections of the central nervous
system (CNS) occur either as bacterial meningitis or as
brain abscess, being localized to the membranes sur-
rounding the brain or in its parenchyma, respectively
[2]. Lipoteichoic acid (LTA), an amphiphilic polymer, is
a component of the Gram-positive bacterial cell wall
that induces glial inflammatory activation in vitro and in
vivo [3,4]. For the initiation of LTA signaling, Toll-like
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responsible for LTA recognition following challenge by
Gram-positive bacteria such as Staphylococcus aureus
and Streptococcus pneumouniae [5,6]. Upon binding to
TLR heterodimers (i.e. TLR2/TLR1 or TLR2/TLR6 com-
plex), LTA exerts a sequential activation of members of
IL-1 receptor-associated kinase (IRAK) family and
tumour-necrosis factor-receptor-associated factor 6
(TRAF6), mediated by a TLR adaptor protein MyD88.
Ultimately, TLR signaling activates proteins of the NF-
B and MAPK families, leading to modulation of gene
expression of cytokines and other pro-inflammatory pro-
teins [7,8].
In the CNS, glial cells such as astrocytes and microglia
are regarded as targets in Gram-positive bacterial infec-
tion [9,10]. Several lines of evidence suggest a causal
relationship between LTA challenges and CNS diseases,
which involves glial activation and TLR2 signaling
[10-12]. In astrocytes of the CNS, TLR signaling has
been shown to be involved in brain inflammatory
changes [13,14], accompanied by up-regulation of sev-
eral genes with pro-inflammatory and pro-apoptotic
capabilities [11,15,16]. However, the role of astrocytes,
the major regulator of fundamental biological functions
of the CNS [17], in LTA-induced brain inflammation
remains poorly defined.
Matrix metalloproteinases (MMPs), a zinc-dependent
proteinases family, are involved in normal development
and wound healing as well as in pathophysiological
implications such as atherosclerosis and tumor metas-
tasis. In brain, an increasing number of studies suggest
an elevation of MMP-9 in various CNS diseases
[18,19]. Moreover, pro-inflammatory factors, including
cytokines, endotoxins, and oxidative stress, have been
reported to up-regulate MMP-9 in astrocytes in vitro
[20,21], indicating that during neuroinflammation,
MMP-9 activity may be regulated by diverse factors in
the CNS. Furthermore, a series of functional element-
binding sites have been identified, including NF-B,
Ets, and AP-1 within the MMP-9 promoter [22], which
can be induced by diverse stimuli. A recent report has
shown that LTA increases MMP-9 expression via ERK
pathway in RAW 264.7 macrophages [23]. Moreover,
our studies have demonstrated that interleukin-1 (IL-
1b), bradykinin (BK) and oxidized low-density lipopro-
tein (oxLDL) up-regulate MMP-9 expression via NF-
B, Elk-1, and AP-1 signalings in rat astrocytes
[20,24,25]. However, the mechanisms underlying the
regulation of MMP-9 expression by LTA in astrocytes
are still unclear.
In response to pathogenic ligands, TLR2/MyD88 acti-
vates PI3K/Akt, MAPKs, and NF-Bp a t h w a y s ,w h i c h
modulate immune responses following ligand recogni-
tion [26-28]. Moreover, activation of these signaling
cascades and transcription factors has been reported to
be involved in induction of MMP-9 in rat astrocytes
[20,24,25]. Moreover, transactivation of receptor tyrosine
kinases such as platelet-derived growth factor receptor
(PDGFR) by several stimuli has also been implicated in
mediating cellular functions of glial cells [29]. More
recently, we have demonstrated that LTA induces
MMP-9 expression via transactivation of PDGFR and
activation of NF-B in astrocytes [30]. Here, we further
investigate the molecular mechanisms underlying LTA-
induced MMP-9 expression in cultured RBA-1 cells.
These findings demonstrate that in RBA-1 cells, LTA-
induced MMP-9 expression is mediated through Ca
2+
signaling pathway, CaMKII-dependent transactivation of
PDGFR, and PI3K/JNK/c-Jun (AP-1). Moreover, LTA-
induced MMP-9 expression is positively associated with
cell motility (migration) in the RBA-1 cell culture
model.
Methods
Materials
DMEM/F-12 medium, FBS, and TRIzol were from Invi-
trogen (Carlsbad, CA, USA). Hybond C membrane and
ECL western blotting detection system were from GE
Healthcare Bio-sciences (Buckinghamshire, UK). MMP-9
antibody was from NeoMarker (Fremont, CA, USA).
Phospho-CaMKII, phospho-JNK, and phospho-c-Jun
antibody kits were from Cell Signaling (Danver, MA,
USA). CaMKII, c-Jun, and phospho-PDGFR antibodies
were from Santa Cruz (Santa Cruz, CA, USA). GAPDH
a n t i b o d yw a sf r o mB i o g e n e s i s( B o u m e m o u t h ,U K ) .
BAPTA/AM, thapsigargin (TG), calmidazolium chloride
(CaMI), KN-62, AG1296, LY294002, SP600125, and tan-
shinone IIA (TSIIA) were from Biomol (Plymouth Meet-
ing, PA, USA). Bicinchoninic acid (BCA) protein assay
reagent was from Pierce (Rockford, IL, USA). LTA
(from Staphylococcus aureus), enzymes, and other che-
micals were from Sigma (St. Louis, MO, USA).
Cell culture
RBA-1 cells were used throughout this study. This cell
line was originated from a primary astrocyte culture of
neonatal rat cerebrum and naturally developed through
successive cell passages [31]. Staining of RBA-1 with the
astrocyte-specific marker, glial fibrillary acid protein
(GFAP), showed over 95% positive staining. In this
study, the RBA-1 cells were used within 40 passages
that show normal cellular morphological characteristics
and had steady growth and proliferation in the mono-
layer system. Cells were cultured and treated as pre-
viously described [32]. Primary astrocyte cultures were
prepared from the cortex of 6-day-old Sprague-Dawley
rat pups as previously described [24]. The purity of pri-
mary astrocyte cultures was assessed with the astrocyte-
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tive astrocytes [30]. The cells were plated on 12-well
plates and 10-cm culture dishes for MMP gelatin zymo-
graphy and RT-PCR, respectively. The culture medium
was changed every 3 days.
MMP gelatin zymography
RBA-1 cells were made quiescent at confluence by incu-
bation in serum-free DMEM/F-12 for 24 h. Growth-
arrested cells were incubated with LTA at 37°C for the
indicated times. When inhibitors were used, they were
added 1 h prior to the application of LTA. Treatment of
RBA-1 cells with pharmacological inhibitors or LTA
alone had no significant effect on cell viability deter-
mined by an XTT assay (data not shown). The culture
media were collected and centrifuged at 4°C to remove
cells and debris, then each sample was mixed with equal
amount of non-reduced sample buffer and electrophor-
esed on 10% SDS-PAGE containing 1 mg/ml gelatin as
a protease substrate. Following electrophoresis, gels
were placed in 2.7% Triton X-100 for 30 min to remove
SDS, and then incubated with developing buffer (50
mM Tris base, 40 mM HCl, 200 mM NaCl, 5 mM
CaCl2, and 0.2% Briji 35; Novex) at 37°C for 24 h on a
rotary shaker. After incubation, gels were stained in 30%
methanol, 10% acetic acid, and 0.5% w/v Coomassie bril-
liant blue for 10 min followed by destaining. Mixed
human MMP-2 and MMP-9 standards (Chemicon) are
used as positive controls. Gelatinolytic activity was man-
ifested as horizontal white bands on a blue background.
Because cleaved MMPs were not reliably detectable,
only pro-form zymogens were quantified.
Total RNA extraction and RT-PCR analysis
For RT-PCR analysis of MMP-9 mRNA expression, total
RNA was extracted from RBA-1 cells as previously
described [32]. The cDNA obtained from 0.5 μgt o t a l
RNA was used as a template for PCR amplification. Oli-
gonucleotide primers were designed based on Genbank
entries for rat MMP-9 and b-actin. The following pri-
mers were used for amplification: for MMP-9, forward
primer 5’-AGTTTGGTGTCGCGGAGCAC-3’;r e v e r s e
primer 5’-TACATGAGCGCTTCCGGCAC-3’;f o rb-
actin, forward primer 5’-GAACCCTAAGGCCAACC
GTG-3’; reverse primer 5’-TGGCATAGAGGTCTTT
ACGG-3’. The amplification was performed in 30 cycles
at 55°C, 30 s; 72°C, 1 min; 94°C, 30 s. PCR fragments
were analyzed on 2% agarose 1× TAE gel containing
ethidium bromide and their size was compared to a
molecular weight markers. Amplification of b-actin, a
relatively invariant internal reference RNA, was per-
formed in parallel, and cDNA amounts were standar-
dized to equivalent b-actin mRNA levels. These primer
sets specifically recognize only the genes of interest as
indicated by amplification of a single band of the
expected size (754 bp for MMP-9 and 514 bp for b-actin)
and direct sequence analysis of the PCR product.
Preparation of cell extracts and western blot analysis
For experiments, cells were made quiescent at conflu-
ence by incubation in serum-free DMEM/F-12 for 24 h.
Growth-arrested RBA-1 were incubated with LTA at
37°C for various times. When inhibitors were used, they
were added 1 h before the application of LTA. The cells
were rapidly washed with ice-cold phosphate-buffered
saline (PBS), scraped, and collected by centrifugation at
1000 ‘ g for 10 min. The collected cells were lysed with
ice-cold lysis buffer containing (mM): 25 Tris-HCl, pH
7.4, 25 NaCl, 25 NaF, 25 sodium pyrophosphate, 1
s o d i u mv a n a d a t e ,2 . 5E D T A ,2 . 5E G T A ,0 . 0 5 %( w / v )
Triton X-100, 0.5% (w/v) SDS, 0.5% (w/v) deoxycholate,
0.5% (w/v) NP-40, 5 mg/ml leupeptin, 5 mg/ml aproti-
nin, and 1 PMSF. The lysates were centrifuged at
45,000 × g for 1 h at 4°C to yield the whole cell extract.
The protein concentration was determined by the BCA
reagents according to the instructions of the manufac-
turer. Samples from these supernatant fractions (30 mg
protein) were denatured and subjected to SDS-PAGE
using a 10% (w/v) running gel. Proteins were transferred
to nitrocellulose (NC) membrane and the membrane
was incubated successively at room temperature with
1% (w/v) BSA in Tween-Tris buffered saline (TTBS) for
1 h. The phosphorylation of CaMKII, PDGFR, JNK, and
c-Jun was determined by Western blot using an anti-
phospho-CaMKII, phospho-PDGFR, phospho-JNK, or
phospho-c-Jun antibody used at a dilution of 1:1000 in
TTBS. Membranes were washed with TTBS four times
for 5 min each, incubated with a 1:2000 dilution of anti-
rabbit horseradish peroxidase antibody for 1 h. The
membrane was extensively washed with TTBS. The
immunoreactive bands were detected by UVP Biospec-
trum® imaging system (Upland, CA, USA).
Measurement of intracellular Ca
2+ level
Intracellular Ca
2+ signaling was measured in confluent
monolayers with the calcium-sensitive dye Fura-2/AM as
described by Grynkiewicz et al. [33]. Upon confluence, the
cells were cultured in serum-free DMEM/F-12 for 24 h
before measurements were made. The monolayers were
covered with 1 ml of DMEM/F-12 containing 5 μM Fura-
2/AM and incubated at 37°C for 45 min. At the end of the
period, the cover slips were washed twice with the physio-
logical buffer solution containing (in mM): 125 NaCl, 5
KCl, 1.8 CaCl2,2M g C l 2,0 . 5N a H 2PO4,5N a H C O 3,1 0
HEPES, and 10 glucose, pH 7.4. The cells were incubated
in physiological buffer for further 30 min to complete dye
de-esterification. The cover slip was inserted into a quartz
cuvette at an angle of approximately 45° to the excitation
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Hitachi F-4500 spectrofluorometer (Tokyo, Japan). Con-
tinuous stirring was achieved with a magnetic stirrer.
Fluorescence of Ca
2+-bound and unbound Fura-2 was
measured by rapidly alternating the dual excitation wave-
lengths between 340 and 380 nm and electronically separ-
ating the resultant fluorescence signals at emission
wavelength 510 nm. The autofluorescence of each mono-
layer was subtracted from the fluorescence data. The ratios
(R) of the fluorescence at the two wavelengths are com-
puted and used to calculate changes in intracellular Ca
2+
level.
Plasmid construction, transient transfection, and
promoter activity assay
The plasmids encoding dominant negative mutant of
JNK (ΔJNK) and shRNA of CaMKII and c-Jun were pro-
vided by Dr. C.C. Chen (Department of Pharmacology,
National Taiwan University, Taipei, Taiwan) and
Dr. C.P. Tseng (Department of Medical Biotechnology
and Laboratory Science, University of Chang Gung).
The upstream region (-1280 to +19) of the rat MMP-9
promoter was cloned to the pGL3-basic vector contain-
ing the luciferase reporter system. Briefly, a 1.3-kb seg-
ment at the 5’-flanking region of the rat MMP-9 gene
was amplified by PCR using specific primers from the
rat MMP-9 gene (accession no. U36476): 5’-ccccggtacc-
GAAGGCGAAATGCTTTGCCC (forward/Kpn1) and
5’-ccccctcgaGGGTGAGAACCGAAGCTTCTG (reverse/
Xho1). The pGL3-Basic vector, containing a polyadeny-
lation signal upstream from the luciferase gene, was
used to construct the expression vectors by subcloning
PCR-amplified DNA of the MMP-9 promoter into the
Kpn1/Xho1 site of this vector. The PCR products
(pGL3-MMP-9WT) were confirmed by their size, as
determined by electrophoresis, and by DNA sequencing.
Additionally, the introduction of a mismatched primer
mutation into the AP-1 to generate pGL3-MMP-9ΔAP-
1 was performed, using the following (forward) primer:
ΔAP-1: 5’-GCAGGAGAGGAAGCTGAGTTGAAGA
CA-3’. MMP-9-luc plasmid was transfected into RBA-1
cells. All plasmids were prepared by using QIAGEN
plasmid DNA preparation kits. These constructs were
transfected into RBA-1 cells, respectively, using a Lipo-
fectamine reagent according to the instructions of man-
ufacture. The transfection efficiency (~60%) was
determined by transfection with enhanced GFP. After
incubation with LTA (50 ng/ml), cells were collected
and disrupted by sonication in lysis buffer (25 mM Tris,
pH 7.8, 2 mM EDTA, 1% Triton X-100, and 10% gly-
cerol). After centrifugation, aliquots of the supernatants
were tested for luciferase activity using the luciferase
assay system. Firefly luciferase activities were standar-
dized for b-galactosidase activity.
Chromatin immunoprecipitation assay
To detect the in vivo association of nuclear proteins
with rat mmp-9 promoter, chromatin immunoprecipita-
tion (ChIP) analysis was conducted as described pre-
viously [24]. RBA-1 cells in 100-mm dishes were grown
to confluence and serum starved for 24 h. After treat-
ment with LTA, protein-DNA complexes were fixed by
1% formaldehyde in PBS. The fixed cells were washed
and lysed in SDS-lysis buffer (1% SDS, 5 mM EDTA, 1
mM PMSF, 50 mM Tris-HCl, pH 8.1) and sonicated on
ice until the DNA size became 200~1000 base pairs.
The samples were centrifuged, and the soluble chroma-
tin was pre-cleared by incubation with sheared salmon
sperm DNA-protein agarose A slurry (Upstate) for 30
min at 4°C with rotation. After centrifugation at 800
rpm for 1 min, one portion of the pre-cleared superna-
tant was used as DNA input control, and the remains
were subdivided into aliquots and then incubated with a
non-immune rabbit immunoglobulin G (IgG; Santa
Cruz), anti-c-Jun (Santa Cruz), respectively, for over-
night at 4°C. The immuno-precipitated complexes of
Ab-protein-DNA were collected by using the above pro-
tein A beads, and washed successively with low-salt buf-
fer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM
Tris-HCl, pH 8.1, 150 mM NaCl), high-salt buffer (same
as the low-salt buffer but with 500 mM NaCl), LiCl buf-
fer (0.25 M LiCl, 1% NP-40, 1% deoxycholate, 1 mM
EDTA, 10 mM Tris-HCl, pH 8.1), and Tris-EDTA (pH
8.0), and then eluted with elution buffer (1% SDS, 100
mM NaHCO3). The cross-linking of protein-DNA com-
plexes was reversed by incubation with 5 M NaCl at 65°
C for 4 h, and DNA was digested with 10 μgo fp r o t e i -
nase K (Sigma)/ml for 1 h at 45°C. The DNA was then
extracted with phenol-chloroform, and the purified
DNA pellet was precipitated with isopropanol. After
washing, the DNA pelletw a sr e s u s p e n d e di nH 2Oa n d
subjected to PCR amplification with the forward (5’-
AGAGCCTGCTCCCAGAGGGC-3’)a n dr e v e r s e( 5 ’-
GCCAAGTCAGGCAGGACCCC-3’), which were speci-
fically designed from the distal AP-1 mmp-9 promoter
region (-557 to -247). PCR products were analyzed on
ethidium bromide-stained agarose gels.
Migration assay
RBA-1 cells were cultured to confluence in 10-cm
dishes and starved with serum-free DMEM/F-12 med-
ium for 24 h. The monolayer cells were scratched
manually with a blade to create extended and definite
scratches in the center of the dishes with a bright and
clear field. The detached cells were removed by washing
the cells once with PBS. Serum-free DMEM/F-12 med-
ium with or without LTA (50 μg / m l )w a sa d d e dt o
each dish as indicated after pretreatment with the inhi-
bitors for 1 h, containing a DNA synthesis inhibitor
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migratory cells from the scratch boundary were
observed and acquired at 0 and 48 h with a digital cam-
era and a light microscope (Olympus, Japan). Numbers
of migratory cells were counted from the resulting four
phase images for each point and then averaged for each
experimental condition. The data presented are sum-
marized from three separate assays.
Statistical analysis of data
Data were estimated using a GraphPad Prism Program
(GraphPad, San Diego, CA, USA). Quantitative data
were analyzed using ANOVA followed by Tukey’sh o n -
estly significant difference tests between individual
groups. Data were expressed as mean ± SEM. A value of
P < 0.05 was considered significant.
Results
LTA-induced proMMP-9 expression is mediated through
c-Jun/AP-1
Recently, we have demonstrated that LTA induces
proMMP-9 up-regulation in astrocytes [30]. Moreover,
MMP-9 promoter contains AP-1 binding sites that are
essential for induction of several inflammatory genes
such as MMP-9 [22,34]. Therefore, we first determined
whether AP-1 was involved in LTA-induced proMMP-9
expression in RBA-1 cells, an AP-1 inhibitor tanshinone
IIA (TSIIA) was used. The concentration of LTA at 50
μg/ml was used throughout this study according to our
previous report (Hsieh et al., 2010) [30]. The condi-
tioned media were collected and analyzed for de novo
synthesis and activity of MMPs by gelatin zymography.
As shown in Figure 1A, pretreatment with TSIIA (0.1-
10 μM) significantly attenuated LTA-induced proMMP-
9 expression and activity. Moreover, pretreatment with
TSIIA (10 μM) also markedly inhibited LTA (50 μg/ml,
16 h)-induced MMP-9 mRNA expression, determined
by RT-PCR (Figure 1B), suggesting that AP-1 is an
important factor in LTA-induced proMMP-9 expression.
To further determine whether an AP-1 subunit c-Jun
was essential for LTA-induced proMMP-9 expression,
cells were incubated with 50 μg/ml LTA for the indi-
cated time intervals. As shown in Figure 1C (upper
panel), LTA stimulated phosphorylation of c-Jun in a
time-dependent manner. There was a significant
increase within 60 min and reached a maximal response
by 90 min. Pretreatment with TSIIA (10 μM) attenuated
LTA-stimulated c-Jun phosphorylation (Figure 1C, lower
p a n e l ) .T oc o n f i r mt h ec r u c i a lr o l eo fc - J u ni nt h e s e
responses, as shown in Figure 1D, transfection with c-
Jun shRNA for 24 h down-regulated endogenous c-Jun
protein expression (upper panel), and significantly atte-
nuated LTA-induced proMMP-9 expression in RBA-1
cells (lower panel). These results suggested that LTA
induces proMMP-9 expression via a c-Jun/AP-1 signal
pathway.
LTA-induced proMMP-9 expression requires JNK1/2
activation
Several studies have demonstrated that JNK, a member
of MAPK family, mediates up-regulation of MMP-9 in
RBA-1 cells [20,25]. Thus, to investigate whether JNK1/
2a l s oi n v o l v e di nL T A - i n d u ced proMMP-9 expression,
a pharmacological inhibitor of JNK1/2, SP600125 was
used. As shown in Figure 2A, pretreatment with
SP600125 (1 μM) significantly inhibited the LTA-
induced proMMP-9 expression during the period of
observation. Moreover, LTA-induced MMP-9 mRNA
expression was also significantly blocked by pretreat-
ment with SP600125, determined by RT-PCR (Figure
2B). To further determine whether LTA-induced
proMMP-9 expression was mediated through JNK1/2
phosphorylation, the kinetics of JNK1/2 phosphorylation
stimulated by LTA was assessed by western blot
using an anti-phospho-JNK1/2 antibody. As shown in
Figure 2C, LTA stimulated JNK1/2 phosphorylation in a
time-dependent manner with a maximal response within
60-90 min, which was significantly inhibited by pretreat-
ment with SP600125 (1 mM) during the period of
observation. Pretreatment with SP600125 (1 μM) also
almost completely inhibited LTA-stimulated c-Jun phos-
phorylation (Figure 2C), suggesting that JNK was an
upstream signal molecule of c-Jun/AP-1 cascade. Thus,
to further ensure that JNK was involved in LTA-induced
proMMP-9 expression, transfection of RBA-1 cells with
a dominant negative mutant of JNK (ΔJNK) was per-
formed. As shown in Figure 2D, transfection with ΔJNK
markedly attenuated proMMP-9 induction by LTA.
These results indicated that LTA-induced proMMP-9
expression is mediated through activation of JNK/c-Jun
cascade in RBA-1 cells.
Calcium-dependent signaling is involved in proMMP-9
induction by LTA
Furthermore, we examined which signaling molecules
participated in activation of the JNK/c-Jun cascade and
up-regulation of MMP-9 by LTA. A recent study has
indicated that induction of MMP-9 by IL-1b is mediated
through Ca
2+-dependent signaling [35]. Hence, we
investigated the role of intracellular Ca
2+ in LTA-
induced proMMP-9 expression, the intracellular Ca
2+
chelator BAPTA/AM and ER Ca
2+-ATPase blocker
thapsigargin (TG) were used. As shown in Figures 3A
and 3B, pretreatment with BAPTA/AM or TG for 24 h
both significantly attenuated LTA-induced proMMP-9
expression in a concentration-dependent manner ana-
lyzed by zymography, suggesting that intracellular Ca
2+
signaling was required for LTA-induced proMMP-9
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intracellular Ca
2+ signaling increase in RBA-1 cells, the
intracellular Ca
2+ was measured by using a Ca
2+ indica-
tor Fura-2/AM. The data showed that LTA rapidly sti-
mulated an intracellular Ca
2+ increase in normal
physiological buffer (Figure 3C). The sources of intracel-
lular Ca
2+ increase may be ascribed to Ca
2+ release from
intracellular stores and Ca
2+ influx from the extracellu-
lar fluid. Therefore, to differentiate these responses, the
same experiments were performed in the Ca
2+-free phy-
siological buffer. As shown in Figure 3D, LTA also sti-
mulated an intracellular Ca
2+ increase under Ca
2+-free
condition, but smaller than those of normal physiologi-
cal buffer. Moreover, pretreatment with TG (1 μM) sig-
nificantly blocked LTA-stimulated intracellular Ca
2+
increase under Ca
2+-free physiological buffer
(Figure 3E). These results indicated that the intracellular
Ca
2+ increase by LTA may come from the intracellular
Figure 1 c-Jun/AP-1 plays a critical role in LTA-induced MMP-9 expression. (A) Time dependence of LTA-induced proMMP-9 expression
and activity. Cells were pretreated with tanshinone IIA (TSIIA, 0.1, 1, or 10 μM) for 1 h and then incubated with 50 μg/ml LTA for the indicated
time intervals. Conditioned media were collected and assayed for proMMP-9 expression and activity by gelatin zymography. ProMMP-2
expression is shown as an internal control. (B) Cells were pretreated with TSIIA for 1 h and then incubated with 50 mg/ml LTA for 16 h. Total
RNA was extracted and analyzed by RT-PCR. (C) Time dependence of LTA-stimulated c-Jun/AP-1 phosphorylation. RBA-1 cells were pretreated
with TSIIA for 1 h and then incubated with 50 mg/ml LTA for the indicated time intervals. Phosphorylation of c-Jun was determined by western
blot using an anti-phospho-c-Jun (p-c-Jun) antibody. (D) Cells were transfected with a c-Jun shRNA plasmid for 48 h, and incubated with LTA for
24 h. The cell lysates were assayed by western blot using an anti-c-Jun antibody and anti-GAPDH antibody as a control (upper panel).
Conditioned media (CM) and cell lysates were analyzed by zymographic analysis and western blot using an anti-GAPDH antibody as a control
(lower panel). Data are expressed as mean ± SEM (A-C) or mean (A, C, D) of three independent experiments (n = 3).
#P < 0.01, as compared with
the cells exposed to LTA alone. The figure represents one of three individual experiments.
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2+ stores and the extracellular Ca
2+
influx which is essential for LTA-induced proMMP-9
expression in RBA-1 cells.
To further determine the effect of Ca
2+ signaling on
LTA-stimulated JNK/c-Jun cascade, the JNK and c-Jun
phosphorylation stimulated by LTA in the presence of
BAPTA/AM or TG were assessed by Western blot. As
s h o w ni nF i g u r e3 F ,p r e t reatment with BAPTA/AM
(30 μM) or TG (1 μM) both markedly attenuated LTA-
stimulated phosphorylation of JNK and c-Jun, suggesting
that intracellular Ca
2+ increase is crucial for phosphory-
lation of JNK/c-Jun stimulated by LTA in RBA-1 cells.
LTA-induced proMMP-9 expression via calmodulin kinase
II (CaMKII)-dependent manner
Several reports have indicated that CaMKII is a media-
tor between calcium signal and MAPK activation such
as JNK [35,36]. To determine whether CaMKII was
involved in LTA-induced proMMP-9 expression in
RBA-1 cells, a CaMKII inhibitor KN-62 and its
upstream molecule, calmodulin (CaM) inhibitor (CaMI)
were used. These data showed that pretreatment with
CaMI (Figure 4A) or KN-62 (Figure 4B) significantly
inhibited LTA-induced proMMP-9 expression in a con-
centration-dependent manner, suggesting that CaM/
Figure 2 LTA-induced c-Jun phosphorylation is mediated through JNK in RBA-1. (A) Cells were pretreated with SP600125 (1 μM) for 1 h
and then incubated with 50 μg/ml LTA for the indicated time intervals. Conditioned media were collected and assayed for proMMP-9
expression and activity by gelatin zymography. ProMMP-2 expression is shown as an internal control. (B) Cells were pretreated with SP600125 for
1 h and then incubated with 50 mg/ml LTA for 16 h. Total RNA was extracted and analyzed by RT-PCR. (C) Time dependence of LTA-stimulated
JNK phosphorylation. RBA-1 cells were pretreated with SP600125 for 1 h and then treated with 50 mg/ml LTA for the indicated time intervals.
Phosphorylation of JNK and c-Jun was determined by western blot using an anti-phospho-JNK or phospho-c-Jun antibody. (D) Cells were
transfected with an empty vector (pcDNA3, as a control) or dominant negative mutant of JNK (ΔJNK) for 24 h, and then exposed to LTA
(50 mg/ml) for 24 h. Cell lysates were assayed by western blot using an anti-GAPDH antibody as a control. Conditioned media were analyzed by
zymographic analysis. Data are expressed as mean ± SEM (A, B, D) or mean (C) of three independent experiments (n = 3).
#P < 0.01, as
compared with the cells exposed to LTA alone. The figure represents one of three individual experiments.
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expression. We also determined whether LTA could sti-
mulate CaMKII activation leading to MMP-9 expression.
As shown in Figure 4C, LTA stimulated a time-depen-
dent phosphorylation of CaMKII. A maximal response
was obtained within 3 min and then declined within 60
min. LTA-stimulated CaMKII phosphorylation was sig-
nificantly attenuated by pretreatment with CaMI (5 μM)
or KN-62 (10 μM) during the period of observation,
respectively (Figure 4D).T oa s c e r t a i nt h a tC a M K I I
indeed participated in LTA-induced proMMP-9 expres-
sion, as shown in Figure 4E, transfection with CaMKII
shRNA significantly knocked down the endogenous
CaMKII protein expression (right panel) and attenuated
LTA-induced proMMP-9 expression (Figure 4E, left
panel), indicating that CaM/CaMKII was involved in
LTA-induced proMMP-9 expression in RBA-1 cells.
Next, to determine whether activation of CaMKII by
LTA was mediated through Ca
2+ signaling, an upstream
signaling molecule of CaM/CaMKII cascade, cells were
Figure 3 LTA-induced Ca
2+ release from internal TG-sensitive Ca
2+ store plays a role in LTA-induced MMP-9 expression. (A, B) Cells
were pretreated with BAPTA/AM or TG for 1 h and then incubated with 50 μg/ml LTA for 24 h. Conditioned media were collected and analyzed
by gelatin zymography. The cell lysates were assayed by western blot using an anti-GAPDH antibody as a control. (C-E) For Ca
2+ mobilization,
confluent cultures of RBA-1 cells on glass coverslips were loaded with Fura-2/AM and fluorescent measurement of [Ca
2+]i was carried out in a
dual excitation wavelength spectrophotometer, with excitation at 340 nm and 380 nm. (C) Cells were incubated in Ca
2+-containing normal
buffer or (D) Ca
2+-free buffer and then exposed to LTA at 100 s. (E) In a Ca
2+-free buffer, cells were pretreated with 1 μM TG for 3 min, exposed
to LTA at 100 s, and then 2 mM Ca
2+ was added to the cells. The figure represents one of at least five similar experiments. (F) Effects of calcium
inhibitors on LTA-induced phosphorylation of JNK and c-Jun, RBA-1 cells were pretreated with BAPTA or TG for 1 h and then incubated with
50 mg/ml LTA for the indicated time intervals. Phosphorylation of JNK and c-Jun was determined by western blot using an anti-phospho-JNK or
phospho-c-Jun antibody. Data are expressed as mean ± SEM (A, B) or mean (F) of three independent experiments (n = 3). *P < 0.05;
#P < 0.01,
as compared with the cells exposed to LTA alone. The figure represents one of at least three individual experiments.
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exposed to LTA (50 μg/ml) for the indicated time inter-
vals. As shown in Figure 5A, LTA-stimulated CaMKII
phosphorylation was significantly inhibited by pretreat-
ment with BAPTA/AM (30 μM, upper panel) or TG (1
μM, lower panel) during the period of observation, sug-
gesting that LTA stimulates phosphorylation of CaMKII
via a Ca
2+-dependent manner. Furthermore, to deter-
mine whether CaMKII mediated LTA-stimulated activa-
tion of JNK/c-Jun cascade, cells were pretreated with
CaMI (5 μM) or KN-62 (10 μM) for 1 h and then trea-
ted with LTA (50 μg/ml) for the indicated time inter-
vals. These data showed that LTA-stimulated
phosphorylation of JNK and c-Jun was significantly
inhibited by pretreatment of CaMI or KN-62 during the
period of observation (Figure 5B). These results indi-
cated that LTA-stimulated Ca
2+-dependent CaM/CaM-
KII cascade was essential for JNK/c-Jun activation and
MMP-9 expression in RBA-1 cells.
LTA induces activation of JNK/c-Jun cascade via CaMKII-
dependent transactivation of PDGFR
Transactivation of growth factor receptor tyrosine
kinases such as PDGFR has been shown to participate
in glial cell functional changes induced by IL-1b [29].
O u rr e c e n ts t u d yh a sa l s od e m o n s t r a t e dt h a tt h e
PDGFR mediates LTA-induced proMMP-9 up-regula-
tion in RBA-1 cells [30]. Therefore, we further examined
Figure 4 Involvement CaMKII in LTA-induced MMP-9 expression in RBA-1. (A, B) Cells were pretreated with inhibitors of calmodulin (CaMI)
or CaM kinase II (KN-62) for 1 h and then incubated with 50 μg/ml LTA for 24 h. Conditioned media were collected and analyzed by gelatin
zymography. Cell lysates were assayed by western blot using an anti-GAPDH antibody as a control. (C) Time dependence of LTA-stimulated
phosphorylation of CaMK II. RBA-1 cells were incubated with 50 μg/ml LTA for the indicated time intervals. (D) Cells were pretreated CaMI or KN-
62 for 1 h and then incubated with LTA for the indicated time intervals. Cell lysates were assayed by western blot using an anti-phospho-CaMKII
antibody. The membranes were stripped and re-probed with anti-GAPDH antibody as a control. (E) Cells were transfected with a CaMKII shRNA
plasmid for 48 h, and then incubated with LTA for 24 h. Cell lysates were assayed by western blot using an anti-CaMKII or anti-GAPDH (as a
control) antibody. Conditioned media were collected and analyzed by gelatin zymography. Data are expressed as mean ± SEM (A-C) or mean
(D) of three independent experiments (n = 3). *P < 0.05;
#P < 0.01, as compared with the cells exposed to LTA alone. The figure represents one
of at least three individual experiments.
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related signaling components were involved in LTA-sti-
mulated JNK/c-Jun cascade. First, RBA-1 cells were pre-
treated with either AG1296 (a PDGFR tyrosine kinase
inhibitor) or LY294002 (a PI3K inhibitor) for 1 h and
then incubated with LTA for the indicated time inter-
vals. We found that pretreatment with either 10 mM
AG1296 or 30 mM LY294002 significantly inhibited
LTA-induced JNK1/2 and c-Jun phosphorylation during
the period of observation revealed by western blot
(Figure 6A). To further ascertain that LTA-stimulated
transactivation of PDGFR was mediated through a Ca
2+-
dependent CaMKII pathway, cells were pretreated with
TLR2 neutralizing antibody (TLR2 nAb, 10 μg/ml),
BAPTA/AM (30 μM), TG (1 μM), CaMI (5 μM), or
KN-62 (10 μM), and then incubated with LTA for the
indicated time intervals. As shown in Figures 6B
and 6C, LTA stimulated a rapidly time-dependent phos-
phorylation of PDGFR, which was markedly attenuated
by pretreatment with TLR2 nAb, BAPTA/AM, TG,
CaMI, or KN-62, indicating that Ca
2+/CaMKII-dependent
transactivation of PDGFR cascade played a critical role in
LTA-induced activation of JNK/c-Jun in RBA-1 cells.
LTA induces c-Jun/AP-1 binding to the MMP-9 promoter
and turned on MMP-9 transcriptional activity
Several studies have reported that the increase of MMP-
9 gene expression is mediated through an AP-1-depen-
dent pathway [37,38]. Moreover, rat MMP-9 promoter
region contains AP-1 binding sites [22,34]. Hence, we
used ChIP-PCR assay to determine whether c-Jun/AP-1
was involved in LTA-regulated MMP-9 gene expression.
W ef i r s td e s i g n e dap a i ro fp r i m e r sf o rM M P - 9p r o m o -
ter (-597 to -318), containing an AP-1 binding site.
Figure 5 Ca
2+/CaMKII-dependent LTA-mediated activation of JNK and c-Jun in RBA-1 cells. (A) Cells were pretreated with BAPTA (upper
part) or TG (lower part) for 1 h and then incubated with LTA for the indicated time intervals. Cell lysates were assayed by western blot using
anti-phospho-CaMKII antibody. (B) Cells were pretreated CaMI or KN-62 for 1 h and then incubated with LTA for the indicated time intervals. Cell
lysates were assayed by western blot using an anti-phospho-JNK or phospho-c-Jun antibody. The membranes were stripped and re-probed with
anti-GAPDH antibody as a control. Data are expressed as mean of three independent experiments (n = 3). *P < 0.05;
#P < 0.01, as compared
with the cells exposed to LTA alone. The figure represents one of at least three individual experiments.
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antibody, and the MMP-9 promoter region (-597 to
-318) was amplified by PCR. As shown in Figure 7A, in
vivo binding of phospho-c-Jun to the MMP-9 promoter
was increased by LTA stimulation in a time-dependent
manner. To further examine whether phospho-c-Jun
binding is mediated through CaMKII-dependent PDGFR
transactivation pathway, as shown in Figure 7A, LTA-
induced phospho-c-Jun binding to the MMP-9 promoter
was significantly inhibited by pretreatment with TG,
KN-62, AG1296, SP600125, or TSIIA, analyzed by a
ChIP-PCR assay, suggesting that Ca
2+/CaMKII-depen-
dent transactivation of PDGFR and JNK is involved in
LTA-induced c-Jun/AP-1 binding to the MMP-9 pro-
moter in RBA-1 cells.
Our recent report has demonstrated that LTA induces
MMP-9 expression via regulating MMP-9 gene tran-
scriptional activity [30]. Here, we further examined
Figure 6 LTA induces MMP-9 expression via Ca
2+/CaMKII-dependent transactivation of PDGFR in RBA-1 cells. (A) Cells were pretreated
with AG1296 (10 μM) or LY294002 (30 μM) for 1 h and then incubated with 50 mg/ml LTA for the indicated time intervals. (B, C) Cells were
pretreated with TLR2 neutralizing antibody (TLR2 nAb), BAPTA, TG, CaMI, or KN-62 for 1 h and then incubated with 50 mg/ml LTA for the
indicated time intervals. Cell lysates were subjected to SDS-PAGE and blotted using an anti-phospho-JNK or anti-phospho-c-Jun (A) and anti-
phospho-PDGFR (B, C) or anti-GAPDH (as an internal control) antibody. Data are expressed as mean ± SEM (B, C) or mean (A) of three
independent experiments (n = 3). *P < 0.05;
#P < 0.01, as compared with the cells exposed to LTA alone. The figure represents one of at least
three individual experiments.
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lated by LTA via AP-1 in RBA-1 cells. The MMP-9 pro-
moter was constructed into a pGL3-basic vector
containing the luciferase reporter system (pGL-MMP-9-
Luc), which contained AP-1 binding sites. To determine
the effect of LTA on the MMP-9 promoter transcrip-
tional activity, cells were cotransfected with these pGL-
MMP-9-Luc construct and pGal and then pretreated
with these inhibitors as mentioned above, following
incubated with LTA (50 mg/ml) for 16 h. As shown in
Figure 7B, pretreatment with TG (1 μM), KN-62 (10
mM), AG1296 (10 μM), SP600125 (1 μM), or TSIIA (10
μM) attenuated LTA-induced in MMP-9 promoter tran-
scriptional activity, suggesting that LTA-induced in
MMP-9 promoter transcriptional activity is mediated
through Ca
2+, CaMKII, PDGFR, JNK, and AP-1 in RBA-
1 cells. To further ensure the AP-1 was critical for
LTA-induced MMP-9 promoter activity via binding to
AP-1 binding element on the MMP-9 promoter region,
the wild-type (WT) MMP-9 promoter mutant by single-
point mutation of the AP-1 binding site (mt-AP1) was
constructed [29]. The data showed that LTA induced
MMP-9 promoter transcriptional activity was signifi-
cantly blocked in cells transfected with mt-AP1-MMP-9
reporter construct (Figure 7C), indicating that AP-1
binding element was required for LTA-induced MMP-9
promoter transcriptional activity. We further demon-
strated that LTA-induced MMP-9 mRNA expression
was also mediated through a Ca
2+/CaMKII-dependent
pathway determined by RT-PCR analysis (Figure 7D).
These results confirmed that LTA-induced MMP-9 pro-
moter activity is mediated through binding of activated
c-Jun/AP-1 to the AP-1 element of the MMP-9 promo-
ter region in RBA-1 cells.
LTA enhances RBA-1 cell migration via up-regulation of
proMMP-9
Ultimately, to demonstrate the functional effect of
proMMP-9 expression induced by LTA on RBA-1 cells,
we evaluated cell migration of RBA-1 cells. The images
of the RBA-1 cell migration were taken and counted at
48 h induction by LTA (50 μg/ml). The number of
migratory RBA-1 cells was counted and the statistical
data were presented in Figure 8A. We found that LTA-
induced cell migration was significantly blocked by pre-
treatment with the inhibitors of intracellular TG-sensitive
Ca
2+ stores (TG, 1 μM), CaMKII (KN-62, 10 mM), JNK
(SP600125, 1 mM), or AP-1 (TSIIA, 10 mM), suggesting
that up-regulation of proMMP-9 and its activity via
CaMKII-dependent AP-1 pathway is required for enhan-
cing cell migration induced by LTA in RBA-1 cells.
To further confirm whether this CaMKII-dependent
AP-1 pathway mediated LTA-induced proMMP-9
expression also occurred in primary culture astrocytes,
Figure 7 c-Jun/AP-1 binding element is essential for LTA-
induced MMP-9 expression through a Ca
2+/CaMKII/PDGFR/
PI3K/JNK pathway in RBA-1 cells. (A) Time dependence of LTA-
stimulated c-Jun/AP-1 binding activity. RBA-1 cells were incubated
with 50 mg/ml LTA for the indicated time intervals, or cells were
pretreated with TG, KN-62, AG1296, SP600125, or TSIIA for 1 h and
then incubated with 50 mg/ml LTA for 30 min. c-Jun/AP-1 binding
activity was analyzed by chromatin-IP (ChIP)-PCR assay. (B) Cells
were transiently cotransfected with pGL-MMP9-Luc and pGal
encoding for b-galactosidase for 24 h. The pGL-MMP-9-Luc-
transfected cells were pretreated with TG, KN-62, AG1296, SP600125,
or TSIIA for 1 h and then incubated with LTA for 16 h. (C) Activation
of wild-type (WT) and AP-1-mutated (mt-AP1) MMP-9 promoter
constructs by LTA. Cells were cotransfected with respective
promoter constructs for 24 h and then incubated with 50 μg/ml
LTA for 16 h. The values for beetle luciferase were normalized to
that of b-galactosidase activity. (D) Cells were pretreated with CaMI,
KN-62, BAPTA, or TG for 1 h and then incubated with LTA for 16 h.
Total RNA were extracted and analyzed by RT-PCR. Data are
expressed as mean ± SEM (B, C) or mean (A, D) of three
independent experiments (n = 3). *P < 0.05;
#P < 0.01, as compared
with the cells exposed to LTA alone. The figure represents one of at
least three individual experiments.
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astrocytes with TG (1 μM), CaMI (5 μM), KN-62 (10
μM), AG1296 (10 μM), LY294002 (30 μM), SP600125
(1 μM), or TSIIA (10 μM) significantly attenuated 50
μg/ml LTA-induced proMMP-9 expression determined
by gelatin zymography. These results demonstrated that
in primary cultured astrocytes, up-regulation of
proMMP-9 by LTA was, indeed, also mediated through
aC a
2+/CaMKII-dependent PDGFR/PI3K/JNK/AP-1
pathway. These results of LTA-induced responses that
appeared in RBA cells are similar to those of rat primary
culture astrocytes.
Discussion
The Gram-positive bacterium Streptococcus pneumoniae
is the most common cause of acute bacterial meningitis
worldwide [39,40], and reveals a close relationship
between LTA challenge and CNS disease. The patho-
genic progression involves glial activation and TLR2
signalings, which are linked to inflammatory neurode-
generation [9,10]. In the CNS, LTA exhibits detrimental
effects on brain cellular functions, including induction
of apoptosis, production of nitrosative and oxidative
stresses, and disruption of BBB following group B Strep-
tococcus or Staphylococcus aureus challenge [9,10,41].
The effects of MMP-9 on CNS diseases have been clari-
fied by specific strategies of MMP-9 inhibition and clini-
cal relevance [24,42,43]. Excessive MMP-9 activity is
associated with sustained inflammation and BBB break-
down, leading to invasive brain injury. Blockade of
MMP-9 activity by pharmacological inhibitors or gene
knock-out strategies provides protective effects for the
brain against cerebral ischemia [42,43]. However, the
molecular mechanisms by which LTA induced MMP-9
expression in RBA-1 cells remain elusive. In this study,
the mechanisms underlying LTA-induced proMMP-9
expression were established by using selective pharma-
cological inhibitors and transfection with dominant
negative mutants coupling with gelatin zymography,
western blotting and RT-PCR analyses. The requirement
of transcription factors for the regulation of LTA-
induced MMP-9 gene expression was determined by
transfection of shRNA and reporter gene assay. These
results suggest that in RBA-1 cells, activation of CaM-
KII-dependent PDGFR/PI3K/JNK linking to c-Jun/AP-1,
mediated through a Ca
2+ signal, is essential for LTA-
induced MMP-9 gene expression and cell migration.
Ca
2+ acts as a second messenger which impacts on a
wide variety of physiological or pathological processes.
Several external stimuli such as LTA stimulate respira-
tory burst in peripheral blood monocytes via increase
intracellular Ca
2+ concentration [44]. In astrocytes, IL-
1b can induce an immediate rise in intracellular free
Ca
2+ concentration under normal conditions [45,46],
Figure 8 LTA induces astrocytic migration through Ca
2
+/CaMKII-dependent c-Jun/AP-1 increasing MMP-9 expression.
RBA-1 cells were plated on coverslips, and grown to confluence.
The coverslips were transferred to new 10-cm dishes containing
serum-free medium for 24 h. The cells were pretreated with TG, KN-
62, SP600125, or TSIIA (containing 10 μM hydroxyurea, a cell
proliferation inhibitor) for 1 h and then incubated with 50 μg/ml
LTA for 48 h. Phase contrast images of RBA-1 cells were taken at 48
h showing the response to LTA (n = 3). The number of LTA-induced
cell migrations at 48 h were counted and summarized in (A). (B)
LTA-induced MMP-9 expression via Ca
2+/CaMKII-dependent PDGFR/
PI3K/JNK/c-Jun cascade is observed in primary culture rat brain
astrocytes. The rat primary culture astrocytes were pretreated with
TG, CaMI, KN-62, AG1296, LY294002, SP600125, or TSIIA for 1 h and
then incubated with LTA for 24 h. The conditioned media were
analyzed by zymographic analysis. Data are expressed as mean ±
SEM (A) or mean (B) of three independent experiments (n = 3). *P <
0.05;
#P < 0.01, as compared with the cells exposed to LTA alone.
(C) Schematic representation of the LTA-mediated signaling
pathways linked to proMMP-9 expression and cell migration in RBA-
1 cells. Stimulation of LTA results in release of intracellular Ca
2+ from
internal stores and activation of CaM/CaMKII-dependent
transactivation of PDGFR and PI3K-JNK cascades, leading to
activation of c-Jnu/AP-1. Activated c-Jun/AP-1 turns on MMP-9 gene
expression and promotes cell motility of RBA-1 cells. This signaling
pathway might contribute to sustained expression of MMP-9 which
is required for RBA-1 cell migration.
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expression [35]. Thus, we observed Ca
2+ responses to
LTA and its effect on MMP-9 expression in RBA-1
cells. First, our data showed that LTA-induced
proMMP-9 expression was attenuated by pretreatment
with Ca
2+ chelator BAPTA/AM and ER Ca
2+-ATPase
inhibitor TG (Figures 3A and 3B), suggesting that intra-
cellular Ca
2+ signal plays an important role in LTA-
induced proMMP-9 expression. Next, we found that
LTA stimulated a transient and rapidly intracellular
Ca
2+ elevation (Figure 3C). The Ca
2+ responses reflect
Ca
2+ mobilization from intracellular Ca
2+ stores and/or
extracellular Ca
2+ influx from the extracellular fluid. We
further demonstrated that LTA stimulates a transient
increase of [Ca
2+]i from the TG-sensitive intracellular
Ca
2+ stores such as ER by using a Ca
2+-free physiologi-
cal buffer and pretreatment with TG (ER Ca
2+-ATPase
inhibitor) (Figures 4D and 4E), consistent with the
report showing that LTA can stimulate intracellular
Ca
2+ rise in tracheal smooth muscle cells [47]. Our data
also showed that LTA-stimulated JNK-c-Jun/AP-1 path-
way is mediated through Ca
2+ responses (Figure 3F),
consistent with that activation of JNK/c-Jun by IL-1b is
mediated through increased intracellular Ca
2+ in astro-
cytes [35]. These results suggest that Ca
2+ release from
the TG-sensitive intracellular Ca
2+ stores may play a cri-
tical role in regulation of LTA-induced proMMP-9
expression in RBA-1 cells.
Calmodulin (CaM) is a key downstream component
responding to Ca
2+ signal. Following binding to Ca
2+,
CaM undergoes a conformational change that renders it
active and able to induce phosphorylation of CaM
kinase II (CaMKII). Since to LTA can stimulate intracel-
lular Ca
2+ increase, we hypothesized that LTA could
activate the CaM/CaMKII pathway that results in
proMMP-9 expression in RBA-1 cells. A previous report
showed that several stimuli can activate a Ca
2+-depen-
dent phosphorylation of CaMKII [48], which may med-
iate MMPs expression in various cell types. For
example, in osteoblastic cells, parathyroid hormone
induces rat collagenase mRNA up-regulation through
CaMKII activation [49]. Our data show that CaM and
CaMKII participated in LTA-induced proMMP-9
expression by pretreatment with their respective inhibi-
tors (Figures 4A and 4B). Moreover, we demonstrated
that LTA can truly stimulate CaMKII phosphorylation
(Figure 4C) which is mediated through Ca
2+ (Figure 5A)
and CaM (Figure 4D). LTA-induced CaMKII-dependent
MMP-9 expression was confirmed by transfection of
cells with CaMKII shRNA (Figure 4E). Furthermore, we
demonstrated that CaM/CaMKII cascade is involved in
LTA-stimulated JNK-c-Jun/AP-1 activation (Figure 5B),
consistent with the idea that MMP-9 induction by IL-1b
is mediated through the CaM/CaMKII system in
astrocytes [35]. For astrocytes, we show for the first
time that LTA stimulates intracellular Ca
2+ increases
from TG-sensitive Ca
2+ stores (e.g. ER), which partici-
pate in LTA-induced CaMKII phosphorylation and
MMP-9 expression.
Several in vivo studies have indicated that PDGFR may
play an important role in brain pathophysiology. Recent
studies have suggested that transactivation of PDGFR
contributes to MMP-9 up-regulation by IL-1b [29] or
LTA [30] in RBA-1 cells. Several kinases, such as c-Src
or PKCs, have been implicated in transactivation of
EGFR or PDGFR [29,50], which in turn activate down-
stream PI3K/Akt and ERK1/2 cascades in various cell
types including glial cells [29]. Several lines of evidence
have also shown that MAPKs and PI3K/Akt mediate
up-regulation of MMP-9 by various stimuli in brain
astrocytes [25,29,32]. Our more recent data have
demonstrated that IL-1b or LTA induces MMP-9
expression via sequential activation of c-Src-dependent
transactivation of PDGFR linking to PI3K/Akt and
ERK1/2 cascade in RBA-1 cells [29,30]. Here, we further
demonstrate a novel pathway of PDGFR transactivation
that may be shared by LTA/TLR system shown to inter-
act with Ca
2+-dependent CaM/CaMKII signaling, which
also contributed to MMP-9 upregulation in astrocytes.
It is consistent with the findings that μ-opioid receptor-
mediated ERK activation involves CaM-dependent EGFR
transactivation [51].
Accumulating evidence has shown that MMP-9 is
upregulated via an AP-1-dependent manner in various
cell types [25,35,52]. AP-1 is an important mediator to
regulate MMP-9 gene expression upon different stimula-
tion [38,53]. Upon stimulation, c-Jun could dimerize
with c-Jun or c-Fos to form stable homodimers or het-
erodimer AP-1 that binds to a specific AP-1 site in the
promoter region of target genes and enhances gene
transcription [54]. Therefore, we investigated the role of
c-Jun, an AP-1 subunit, in LTA-induced proMMP-9
expression. Our data show that c-Jun phosphorylation is
essential for LTA-induced proMMP-9 expression (Fig-
ure 1). We found that pretreatment with AP-1 inhibitor
(TSIIA) attenuated LTA-induced c-Jun phosphorylation
and MMP-9 mRNA and protein levels. Such inhibitory
effects were also achieved by transfection with shRNA
for c-Jun on proMMP-9 expression (Figure 1D). Theses
results are consistent with the known mechanisms of
MMP-9 expression in human breast cancer cells [52]
and astrocytes [25,35].
Moreover, AP-1 binding sites have been identified in
the MMP-9 gene promoter [55], which might explain
the modulation of exerted by LTA through AP-1 activa-
tion. To examine whether c-Jun/AP-1 indeed binds to
AP-1 sites in the promoter region of MMP-9 gene, the
binding activity of c-Jun/AP-1 was determined by a
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phospho-c-Jun binding to MMP-9 promoter in a time-
dependent manner (Figure 7A), consistent with the
responses of phosphorylation of c-Jun (Figure 1C). Pre-
treatment of RBA-1 cells with TG, KN-62, AG1296,
SP600125, or TSIIA markedly inhibited LTA-stimulated
c-Jun/AP-1 binding to MMP-9 promoter (Figure 7A).
These results suggest that LTA-stimulated c-Jun/AP-1
binding activity is mediated via a Ca
2+/CaMKII-depen-
dent JNK/c-Jun cascade, consistent with the idea that
CaMKII-dependent JNK/c-Jun activation is involved in
cytokine-stimulated AP-1 activation [35,56]. Subse-
quently, we also demonstrated LTA-stimulated MMP-9
transcriptional activity via the same pathway using a
wild-type rat MMP-9 promoter-luciferase reporter plas-
mid (pGL-MMP-9-Luc) construct (Figure 7B). We
further confirmed that the AP-1 binding site within the
MMP-9 promoter is required for LTA-induced MMP-9
transcriptional activity by mutation of the AP-1 element
on MMP-9 promoter activity (Figure 7C). Furthermore,
our RT-PCR data also demonstrate that Ca
2+-dependent
CaMKII signaling molecules are involved in LTA-
induced MMP-9 gene upregulation in RBA-1 cells (Fig-
ure 7D). These results indicate that LTA-induced
MMP-9 expression is mediated through Ca
2+/CaMKII-
dependent PDGFR/PI3K/JNK pathway, associated with
activation of transcription factor c-Jun/AP-1 in RBA-1
cells. Consistently, we also confirmed that rat brain pri-
mary culture astrocytes use the same identified signaling
molecules to express MMP-9 under LTA stimulation
(Figure 8B).
Cell motility is a fundamental process during embryo-
nic development, wound healing, inflammatory
responses, and tumor metastasis [57]. It has been
reported that MAPKs, NF-B, AP-1, and MMP-9
[24,25,58] contribute to cell motility in different cell
types. Recently, we have demonstrated that a c-Src-
dependent NF-B pathway mediates LTA-induced
MMP-9 expression and cell migration in RBA-1 cells
[30]. Here, we further demonstrate that a Ca
2+/CaMKII-
dependent JNK/c-Jun pathway is involved in LTA-
induced cell migration in RBA-1 cells (Figure 8A).
Therefore, we suggest that upregulation of MMP-9 by
LTA is essential for enhancing RBA-1 cell migration
which is mediated through the Ca
2+/CaMKII-dependent
JNK/c-Jun pathway.
Conclusion
These results demonstrate that LTA induces MMP-9
expression via sequential activation of Ca
2+, CaMKII,
PDGFR, PI3K, JNK, and transcription factor c-Jun/AP-1,
leading to the promotion of astrocytic migration. Based
on observations from the literature and on our findings,
we depict in Figure 8C a model for Ca
2+/CaMKII-
dependent transactivation of the PDGFR pathway impli-
cated in LTA-induced MMP-9 expression in RBA-1
cells. Although the molecular basis of CaMKII function
in synaptic and behavioral memory is well established,
the role of CaMKII during acute or chronic brain
inflammation is still unclear. We demonstrate that
CaMKII is a pivotal kinase linking Ca
2+ signal and JNK,
and that this leads to expression of MMP-9 in CNS
infection. Pharmacological approaches targeting MMP-9
and their specific upstream signaling components
should yield useful therapeutic targets for CNS inflam-
matory diseases upon infection with Gram-positive
bacteria.
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